Kutatási jelek – Signal Engine

• Research | Paul Nghiem Laboratory — Merkel cell carcinoma
• AbbVie Announces Positive Results from CLL14, a Phase 3 Trial Evaluating a Venetoclax Combination as First-Line Therapy with a Fixed Duration of Treatment in Patients with Chronic Lymphocytic Leukemia — Chronic lymphocytic leukemia
• The Relevance of the RELEVANCE Trial in Follicular Lymphoma — Prostate cancer
• The Past, Present, and Future of Pancreatic Cancer Clinical Trials — Pancreatic cancer
• Exploring a New Treatment for Metastatic Colorectal Cancer — Colorectal cancer
• Clinical Trials at Penn Pancreatic Cancer Research Center — Pancreatic cancer
• Can Immunotherapy Succeed in Glioblastoma? — Glioblastoma
• Immunotherapy Expands Lung Cancer Treatment Options — NSCLC
• Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma — Anal squamous cell carcinoma
• Leiomyosarcoma in 2018 – where we are and where we need to go. — Leiomyosarcoma
• Researchers Develop Antibody to Fight Colorectal Cancer — Colorectal cancer
• Melanoma Clinical Trials | Melanoma | UT Southwestern Medical Center — Melanoma
• Thoracic Cancer Research - Penn State Cancer Institute — NSCLC
• Research Projects - Leiomyosarcoma.info — Leiomyosarcoma
• Abbas Looks at the Use of Ruxolitinib and Fedratinib in Myelofibrosis — Myelofibrosis
• Novel targeted therapies and immunotherapy for advanced thyroid cancers — Thyroid cancer
• Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus — Esophageal cancer
• Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle‑Cell Lymphoma — Lymphoma
• Regorafenib Improves Progression‑Free Survival in Metastatic Osteosarcoma — Osteosarcoma
• Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non‑Germinal Center B‑Cell Diffuse Large B‑Cell Lymphoma — Diffuse large B-cell lymphoma